Protagonist Therapeutics, based in Menlo Park, is a pioneering biotechnology company that has developed ReCode, the first genetic medicines platform designed for precise delivery to organs, tissues, and cells outside of the liver.
The company's pipeline of rare disease therapeutics utilizes optimized mRNA and gene correction technologies with the unique ability for redosing, offering innovative solutions for addressing unmet medical needs in the field of genetic medicine.
Generated from their website's infomation
